AKESF
Price
$19.10
Change
+$0.36 (+1.92%)
Updated
Sep 5 closing price
Capitalization
18.27B
BNTX
Price
$102.58
Change
-$9.88 (-8.79%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
27.04B
56 days until earnings call
Interact to see
Advertisement

AKESF vs BNTX

Header iconAKESF vs BNTX Comparison
Open Charts AKESF vs BNTXBanner chart's image
AKESO
Price$19.10
Change+$0.36 (+1.92%)
Volume$150
Capitalization18.27B
BioNTech SE American Depositary Share
Price$102.58
Change-$9.88 (-8.79%)
Volume$22.7K
Capitalization27.04B
AKESF vs BNTX Comparison Chart in %
Loading...
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKESF vs. BNTX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKESF is a Hold and BNTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (AKESF: $19.10 vs. BNTX: $112.46)
Brand notoriety: AKESF and BNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKESF: 4% vs. BNTX: 287%
Market capitalization -- AKESF: $18.27B vs. BNTX: $27.04B
AKESF [@Biotechnology] is valued at $18.27B. BNTX’s [@Biotechnology] market capitalization is $27.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKESF’s FA Score shows that 1 FA rating(s) are green whileBNTX’s FA Score has 2 green FA rating(s).

  • AKESF’s FA Score: 1 green, 4 red.
  • BNTX’s FA Score: 2 green, 3 red.
According to our system of comparison, BNTX is a better buy in the long-term than AKESF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKESF’s TA Score shows that 4 TA indicator(s) are bullish while BNTX’s TA Score has 7 bullish TA indicator(s).

  • AKESF’s TA Score: 4 bullish, 4 bearish.
  • BNTX’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, BNTX is a better buy in the short-term than AKESF.

Price Growth

AKESF (@Biotechnology) experienced а -11.26% price change this week, while BNTX (@Biotechnology) price change was +12.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.13%. For the same industry, the average monthly price growth was +10.99%, and the average quarterly price growth was +33.00%.

Reported Earning Dates

BNTX is expected to report earnings on Nov 03, 2025.

Industries' Descriptions

@Biotechnology (+2.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($27B) has a higher market cap than AKESF($18.3B). BNTX has higher P/E ratio than AKESF: BNTX (161.76) vs AKESF (25.37). AKESF YTD gains are higher at: 172.857 vs. BNTX (-1.308).
AKESFBNTXAKESF / BNTX
Capitalization18.3B27B68%
EBITDAN/A-72.1M-
Gain YTD172.857-1.308-13,220%
P/E Ratio25.37161.7616%
RevenueN/A2.88B-
Total CashN/A14B-
Total DebtN/A270M-
FUNDAMENTALS RATINGS
BNTX: Fundamental Ratings
BNTX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKESFBNTX
RSI
ODDS (%)
Bearish Trend 4 days ago
54%
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
75%
Momentum
ODDS (%)
Bearish Trend 4 days ago
54%
Bullish Trend 4 days ago
72%
MACD
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
49%
Bullish Trend 4 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
47%
Bullish Trend 4 days ago
72%
Advances
ODDS (%)
Bullish Trend 22 days ago
78%
Bullish Trend 4 days ago
75%
Declines
ODDS (%)
Bearish Trend 5 days ago
61%
Bearish Trend 11 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bullish Trend 4 days ago
69%
Bearish Trend 4 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SGOL34.280.43
+1.27%
abrdn Physical Gold Shares ETF
XTWO49.550.07
+0.15%
BondBloxx Bloomberg Two YrTrgDurUSTrsETF
PCMM50.530.07
+0.14%
BondBloxx Private Credit CLO ETF
ZALT31.63N/A
N/A
Innovator U.S. Equity 10 Buffr ETF - Qt
XTAP39.28-0.05
-0.13%
Innovator US Equity Acltd Pls ETF™ April

AKESF and

Correlation & Price change

A.I.dvisor tells us that AKESF and LGVN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKESF and LGVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKESF
1D Price
Change %
AKESF100%
+1.95%
LGVN - AKESF
24%
Poorly correlated
+5.84%
BNTX - AKESF
24%
Poorly correlated
+8.66%
EVAX - AKESF
23%
Poorly correlated
+8.35%
ALGS - AKESF
21%
Poorly correlated
+5.59%
AURX - AKESF
20%
Poorly correlated
-2.73%
More

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with SMMT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
+8.66%
SMMT - BNTX
52%
Loosely correlated
+9.16%
TIL - BNTX
52%
Loosely correlated
+3.89%
MRNA - BNTX
47%
Loosely correlated
+3.54%
KYMR - BNTX
47%
Loosely correlated
+3.10%
NVAX - BNTX
43%
Loosely correlated
+1.41%
More